Compare with LOTUS EYE CARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs LOTUS EYE CARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS LOTUS EYE CARE KRSNAA DIAGNOSTICS/
LOTUS EYE CARE
 
P/E (TTM) x - 38.6 - View Chart
P/BV x 9.2 2.4 389.8% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 KRSNAA DIAGNOSTICS   LOTUS EYE CARE
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
LOTUS EYE CARE
Mar-21
KRSNAA DIAGNOSTICS/
LOTUS EYE CARE
5-Yr Chart
Click to enlarge
High RsNA55 0.0%   
Low RsNA20 0.0%   
Sales per share (Unadj.) Rs998.815.6 6,418.4%  
Earnings per share (Unadj.) Rs284.50.8 37,740.6%  
Cash flow per share (Unadj.) Rs342.11.9 18,254.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %NM1.3- 
Book value per share (Unadj.) Rs355.525.3 1,403.0%  
Shares outstanding (eoy) m6.5020.80 31.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x02.4 0.0%   
Avg P/E ratio x049.3 0.0%  
P/CF ratio (eoy) x019.8 0.0%  
Price / Book Value ratio x01.5 0.0%  
Dividend payout %066.3 0.0%   
Avg Mkt Cap Rs m0773 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m29668 433.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,492324 2,005.7%  
Other income Rs m1227 1,646.8%   
Total revenues Rs m6,615331 1,997.7%   
Gross profit Rs m3,46637 9,302.1%  
Depreciation Rs m37423 1,606.8%   
Interest Rs m2591 17,767.1%   
Profit before tax Rs m2,95520 14,831.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1054 26,066.7%   
Profit after tax Rs m1,84916 11,793.9%  
Gross profit margin %53.411.5 463.8%  
Effective tax rate %37.421.3 175.7%   
Net profit margin %28.54.8 588.0%  
BALANCE SHEET DATA
Current assets Rs m2,481136 1,824.0%   
Current liabilities Rs m1,83858 3,159.2%   
Net working cap to sales %9.924.1 41.2%  
Current ratio x1.42.3 57.7%  
Inventory Days Days2549 51.0%  
Debtors Days Days4184 48.8%  
Net fixed assets Rs m3,564449 794.6%   
Share capital Rs m2,489208 1,196.8%   
"Free" reserves Rs m-178319 -55.9%   
Net worth Rs m2,310527 438.4%   
Long term debt Rs m1,6800-   
Total assets Rs m6,045585 1,034.2%  
Interest coverage x12.414.6 84.6%   
Debt to equity ratio x0.70-  
Sales to assets ratio x1.10.6 193.9%   
Return on assets %34.92.9 1,189.8%  
Return on equity %80.03.0 2,690.0%  
Return on capital %80.54.1 1,985.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1,02627 3,744.4%  
From Investments Rs m-6115 -12,580.0%  
From Financial Activity Rs m308-3 -9,402.4%  
Net Cashflow Rs m72329 2,494.3%  

Share Holding

Indian Promoters % 27.4 39.0 70.3%  
Foreign collaborators % 0.0 18.8 -  
Indian inst/Mut Fund % 34.6 0.0 -  
FIIs % 4.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 42.3 171.8%  
Shareholders   75,065 6,226 1,205.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    DR. LAL PATHLABS    MAX HEALTHCARE INSTITUTE    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 28, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 5-YR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS